Related Experiment Videos
Fertility preservation in oncology
1Department of Obstetric and Gynecology, McGill Reproductive Center, McGill University, Royal Victoria Hospital, Montreal, Canada. Hananel.holzer@muhc.mcgill.ca
Minerva Ginecologica
|March 11, 2005
Summary
Cancer treatments increasingly threaten fertility in young females. Fertility preservation options like oocyte cryopreservation and ovarian tissue banking offer hope, but require personalized strategies and patient counseling.
Area of Science:
- Reproductive Medicine
- Oncology
- Oncofertility
Background:
- Cancer survival rates for childhood and pre-pubertal females are rising.
- Lifesaving cancer treatments (chemotherapy, radiotherapy) pose significant risks to fertility, potentially causing oocyte loss and premature ovarian failure.
Purpose of the Study:
- To review current fertility preservation options for female cancer patients.
- To discuss the efficacy and experimental nature of various oncofertility strategies.
Main Methods:
- Ovarian transposition to reduce radiation dose.
- Embryo cryopreservation and oocyte cryopreservation/vitrification.
- In-vitro maturation of oocytes from unstimulated ovaries.
- Ovarian tissue cryopreservation and autotransplantation.
Main Results:
- Ovarian transposition is beneficial for patients under 40.
- Established methods include embryo and oocyte cryopreservation.
- Ovarian tissue cryopreservation holds promise but requires addressing risks like malignant cell transmission and graft survival.
- Limited success reported for ovarian tissue transplantation.
Conclusions:
- Fertility preservation strategies must be individualized based on patient age, partnership status, cancer type, treatment, and available time.
- Patients must be informed about the experimental nature of some fertility preservation methods.